DaVinci Registry(Distinctly Assess Vision in Coronary Intervention)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00243438
Recruitment Status : Completed
First Posted : October 24, 2005
Last Update Posted : January 28, 2009
Information provided by:
Abbott Vascular

October 21, 2005
October 24, 2005
January 28, 2009
July 2003
March 2005   (Final data collection date for primary outcome measure)
TVF [ Time Frame: 9 months ]
Not Provided
Complete list of historical versions of study NCT00243438 on Archive Site
  • Mode of death
  • Time to first MI
  • TVR
  • CABG
Not Provided
Not Provided
Not Provided
DaVinci Registry(Distinctly Assess Vision in Coronary Intervention)
Distinctly Access Vision In Coronary Interventions
Prospective Internet-Registry, Postmarketing-Surveillance, Registration and Follow-up of patients after Multi-Link VISION™ - Stent Implantation
A Non-Randomized prospective evaluation of the Multi-Link Rx Vision TM Coronary Stent System in the treatment of patients with De novo native coronary artery lesions
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Patients with diabetes and/or complex coronary artery disease who are treated with a Multi-Link Vision™ Stent.
Coronary Disease
Device: Multilink Vision™ Stent (CE-labeled)
Patients who have diabetes and/or complex lesions and who have had a Multilink Vision™ Stent placed.
Patients who have received a Vision stent and who have diabetes and/or complex lesions.
Intervention: Device: Multilink Vision™ Stent (CE-labeled)
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
Same as current
March 2005
March 2005   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Women and Men Age >18 years, Intention to treat all stenosis with Multi-Link VisionTM Stents, documented patient consent

Exclusion Criteria:

  • No Multi-Link Vision™ Stent implanted, life expectation >9 M, cardiogenic shock, STEMI, NSTEMI or unstable angina pectoris with pathologic markers within the last 48 hours, intolerance of Clopidogrel/ Tiklopidin
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
Version vom 18.7.2003
Not Provided
Not Provided
Matt Kiely, Abbott Vascular
Abbott Vascular
Not Provided
Principal Investigator: Christian Hamm, MD Kerckhoff-Klinik/ Benekestr. 2-8/ 61231 Bad Nauheim
Abbott Vascular
January 2009